Condition: Neoplasms · Neoplasm Metastasis · Metastatic Gastrointestinal Carcinoid Tumor · Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
This study is to evaluate the safety and antitumor activity of EMB-01 in advanced/metastatic gastrointestinal cancers, including gastric cancer, hepatocellular cancer, cholangiocarcinoma and colorectal cancer.
This description comes directly from the study's public registry record.
Rong Wang, M.Sc · +86-21-61043299 · CT.info@epimab.com
Di Hu, M.Sc · +862161043299 · CT.info@epimab.com
Always discuss trial participation with your own doctor first.
| MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Beijing cancer Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Nanfang Hospital | Guangzhou, Guangdong, China | Recruiting |
| Hunan Cancer Hospital | Changsha, China | Recruiting |
| West China Hospital, Sichuan University | Chengdu, China | Recruiting |
| The Sixth Affiliated Hospital of Sun Yat-Sen University | Guangzhou, China | Recruiting |
| Sir Run Run Shaw Hospital, Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| Harbin Medical University Cancer Hospital | Harbin, China | Recruiting |
| Shandong Cancer Hospital | Jinan, China | Recruiting |
| Gansu Provincial Hospital | Lanzhou, China | Recruiting |
| The Affiliated hospital of Qingdao University | Qingdao, China | Not Yet Recruiting |
| Fudan University Shanghai Cancer Center | Shanghai, China | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05176665